bioRxivImmunologyPreprint
Ability of mycobacterial pathogens to establish a persistent infection is lost by deletion of a single gene, rel, regulator of the stringent response
A. H. A. Mahmoud, G. S. Abdellrazeq, L. M. Fry, D. A. Schneider, S. Attreed, L. Burton, N. Sangewar, W. Mwangi, C. deSouza, V. Hulubei, W. C. Davis, K. T. Park
Abstract
Studies in a mouse model revealed Mycobacterium tuberculosis (Mtb) with a deletion of rel, regulator of the stringent response, could not establish a persistent infection. Studies in cattle with a Mycobacterium. a. paratuberculosis rel deletion mutant revealed inability to establish a persistent infection was associated with development of CD8 cytotoxic T cells (CTL) that kill intracellular bacteria. Further comparative studies ex vivo with Mbv Calmette-Guerin (BCG) and a BCG rel deletion mutant revealed no clear difference in development of CTL in vitro. As reported, a study of the recall response was conducted with cattle vaccinated with either BCG or with BCGrel, to determine if information could be obtained that would show how gene products under control of rel interfere with the CTL response to mycobacterial pathogens in vivo. The study revealed the CTL response elicited by vaccination with BCG was impaired, in comparison with the response elicited by BCGrel. Comparative analysis of the recall response ex vivo revealed the functional impairment was not associated with the timing of appearance of the recall response, expression of IFN-{gamma}, TNF-, IL-17, or IL-22, or molecules that mediate intracellular killing. Further studies are needed to determine how CD8 CTL functional activity is modulated in vivo by gene products regulated by rel.
- organism: mouse
- organism: chicken / avian
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- c-Myc inhibits macrophage antimycobacterial response in Mycobacterium tuberculosis infection
Edoardo Sarti, Cédric Dollé, … Johannes Nemeth·The Journal of Infectious DiseasesPeer-reviewed·Aug 26, 2025
- Antibiotic treatment shapes antigen presentation during chronic TB infection, offering novel targets for therapeutic vaccination
Y.-M. Chuang, N. K. Dutta, … P. C. Karakousis·bioRxiv·May 15, 2019
- TLR2 on CD4+ and CD8+ T cells promotes late control of Mycobacterium tuberculosis infection
S. Reba, Q. Li, … R. E. Rojas·bioRxiv·May 19, 2021
- MDSC depletion during immunization with heat-killed Mycobacterium tuberculosis increases protection against BCG infection.
Arpa Aintablian, Anna M. Arold, … Manfred Bernhard Lutz·Frontiers in ImmunologyPeer-reviewed·Jul 31, 2025
- Mycobacterium tuberculosis infection boosts B cell responses to unrelated pathogens
S. G. Kimuda, I. Andia-Biraro, … S. Cose·bioRxiv·Jun 25, 2019
- MIP3α-RelMtb intranasal DNA vaccination induces reactive T-cell infiltration into the lungs in mice and macaques
James T. Gordy, Jean J. Zheng, … Richard B. Markham·VaccinePeer-reviewed·Jul 16, 2025